Select the search type
 
  • Site
  • Web
Search
You are here:   animal list > Jorunna funebris

 

Minimize

 

Jorunna funebris Kelaart 1858 

Dotted Nudibranch

 Sean Maxwell (2011)

 

Fact Sheet

Minimize
Overview

Brief Summary


Comprehensive Description


Distribution


Physical Description

Size


Identification Resources


Ecology

Local Distribution and Habitats


Biogeographical Distribution


Micro-habitats and Associations


Crypsis


Life History & Behaviour

Behaviour


Cyclicity


Evolution & Systematics

Fossil History


Systematics or Phylogenetics


Morphology & Physiology

External Morphology


Internal Anatomy


Molecular Biology & Chemistry

Molecular Biology


Secondary Metabolites


Conservation

Trends


Threats


References & More Information

References


Contacts


Names & Taxonomy

Related Names


Common Names

Threats


Bioprospecting poses a potential threat to dotted nudibranchs. Jorumycin, which is a secondary metabolite produced by J. funebris (see Molecular Biology and Chemistry), is a dimeric isoquinoline alkaloid with cytotoxc properties against tumor cell lines (Fontana et al. 2000, Fontana et al. 2001, Charupant at al. 2007). 

Human society has a lot to gain from a new remedy for cancer sufferers, and if extraction processes continue to be refined, jorumycin presents a potential low cost and effective way to kill human cancer cells. If jorumycin is to become a viable option for cancer remediation, it is likely that dotted nudibranch populations will suffer from additional anthropogenic pressure.

Consequently, J. funebris populations will need to be monitored and, if required, managed to ensure the persistence of the species.     

Classification

Minimize